Patent Yard Sign in
Canadian application, no grantCanada

Processes for producing epsilon caprolactams

CA 2285745 A1 · Owner: Eisenschmid, Thomas Carl · Inventors: Maher, John Michael; Olson, Kurt Damar; Packett, Diane Lee

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

This invention relates in part to processes for producing one or more substituted or unsubstituted epsilon caprolactams e.g. epsilon caprolactam, which comprises: (a) subjecting one or more substituted or unsubstituted alkadienes to hydroxycarbonylation in the presence of a hydroxycarbonylation catalyst, e.g. a metal-organophosphorus ligand complex catalyst and , neutralization with a base to produce one or more substituted or unsubstituted pentenoic acid salts; (b) subjecting said one or more substituted or unsubstituted pentenoic acid salts to hydroformylation in the presence of a hydroformylation catalyst, e.g. a metal-organophosphorus ligand complex catalyst, to produce one or …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 14, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 14, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 14, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 14, 1998
GrantedNo grant recorded
Term endedApril 14, 2018
Patent numberCA 2285745 A1
Classification (IPC)C07D201/08 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedApril 14, 1998Term endedApril 14, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.